Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

So Yeon Jeon

Showing results (41-50 of 91) with videos related to

Pageof 10
Sort By:
Bioengineering (Basel, Switzerland)|September 28, 2023
Deep Learning of Speech Data for Early Detection of Alzheimer's Disease in the ElderlyKichan Ahn, Minwoo Cho, Suk Wha Kim, et al.
Annals of Hematology|November 13, 2019
Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic IndexSung Kyun Yim, Ho-Young Yhim, Yeon-Hee Han, et al.
Neurobiology of Aging|December 16, 2018
Influence of hypertension on brain amyloid deposition and Alzheimer's disease signature neurodegenerationSo Yeon Jeon, Min Soo Byun, Dahyun Yi, et al.
Neuroreport|December 4, 2018
Neurometabolite changes in patients with complex regional pain syndrome using magnetic resonance spectroscopy: a pilot studyYe-Ha Jung, Hyeonjin Kim, So Yeon Jeon, et al.
Psychiatry and Clinical Neurosciences|December 17, 2022
Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive declineSo Yeon Jeon, Min Soo Byun, Dahyun Yi, et al.
Frontiers in Aging Neuroscience|October 20, 2018
Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic PracticeJun Ho Lee, Min Soo Byun, Dahyun Yi, et al.
Leukemia Research|March 9, 2012
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular responseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.
Acta Haematologica|November 5, 2015
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual DiseaseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.
Cancer Research and Treatment|March 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) StudySo-Yeon Jeon, Hye Sook Han, Woo Kyun Bae, et al.
Pain Medicine (Malden, Mass.)|July 10, 2018
Brain Metabolites and Peripheral Biomarkers Associated with Neuroinflammation in Complex Regional Pain Syndrome Using [11C]-(R)-PK11195 Positron Emission Tomography and Magnetic Resonance Spectroscopy: A Pilot StudyYe-Ha Jung, Hyeonjin Kim, So Yeon Jeon, et al.
Pageof 10

Showing results (41-50 of 91) with videos related to

Sort By:
Pageof 10
Bioengineering (Basel, Switzerland)|September 28, 2023
Deep Learning of Speech Data for Early Detection of Alzheimer's Disease in the ElderlyKichan Ahn, Minwoo Cho, Suk Wha Kim, et al.
Annals of Hematology|November 13, 2019
Early risk stratification for diffuse large B-cell lymphoma integrating interim Deauville score and International Prognostic IndexSung Kyun Yim, Ho-Young Yhim, Yeon-Hee Han, et al.
Neurobiology of Aging|December 16, 2018
Influence of hypertension on brain amyloid deposition and Alzheimer's disease signature neurodegenerationSo Yeon Jeon, Min Soo Byun, Dahyun Yi, et al.
Neuroreport|December 4, 2018
Neurometabolite changes in patients with complex regional pain syndrome using magnetic resonance spectroscopy: a pilot studyYe-Ha Jung, Hyeonjin Kim, So Yeon Jeon, et al.
Psychiatry and Clinical Neurosciences|December 17, 2022
Circadian rest-activity rhythm and longitudinal brain changes underlying late-life cognitive declineSo Yeon Jeon, Min Soo Byun, Dahyun Yi, et al.
Frontiers in Aging Neuroscience|October 20, 2018
Prediction of Cerebral Amyloid With Common Information Obtained From Memory Clinic PracticeJun Ho Lee, Min Soo Byun, Dahyun Yi, et al.
Leukemia Research|March 9, 2012
Imatinib mesylate discontinuation in patients with chronic myeloid leukemia who have received front-line imatinib mesylate therapy and achieved complete molecular responseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.
Acta Haematologica|November 5, 2015
Long-Term Outcomes after Imatinib Mesylate Discontinuation in Chronic Myeloid Leukemia Patients with Undetectable Minimal Residual DiseaseHo-Young Yhim, Na-Ri Lee, Eun-Kee Song, et al.
Cancer Research and Treatment|March 8, 2018
A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Patients Receiving Moderately Emetogenic Chemotherapy: Results of the Korean South West Oncology Group (KSWOG) StudySo-Yeon Jeon, Hye Sook Han, Woo Kyun Bae, et al.
Pain Medicine (Malden, Mass.)|July 10, 2018
Brain Metabolites and Peripheral Biomarkers Associated with Neuroinflammation in Complex Regional Pain Syndrome Using [11C]-(R)-PK11195 Positron Emission Tomography and Magnetic Resonance Spectroscopy: A Pilot StudyYe-Ha Jung, Hyeonjin Kim, So Yeon Jeon, et al.
Pageof 10